Literature DB >> 2394818

Surgical treatment of adolescent hallux valgus.

A E Geissele1, R P Stanton.   

Abstract

Surgical for adolescent hallux valgus (HV) was performed on 32 feet. Five feet (16%) required revision surgery, and technical errors accounted for recurrence in all five. Satisfaction was obtained in 70% of patients. According to a new bunion rating score, 59% of patients had good to excellent results. In a subgroup of patients treated with metatarsal osteotomy for metatarsus primus varus, the Mitchell osteotomy provided an excellent rating in 95% of patients. Surgery for adolescent HV provides satisfying results in most patients. The one factor most highly correlated with both decreased risk of recurrence of angular deformity and patient satisfaction was a reduction of the intermetatarsal (IM) angle.

Entities:  

Mesh:

Year:  1990        PMID: 2394818     DOI: 10.1097/01241398-199009000-00014

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  5 in total

1.  [Not Available].

Authors:  M J Coughlin
Journal:  Oper Orthop Traumatol       Date:  1999-06       Impact factor: 1.154

2.  Outcome of the scarf osteotomy in adolescent hallux valgus.

Authors:  H L George; J Casaletto; P N Unnikrishnan; D Shivratri; L A James; Alfie Bass; Colin E Bruce
Journal:  J Child Orthop       Date:  2009-05-07       Impact factor: 1.548

3.  Surgical treatment of hallux valgus associated with flexible flatfoot during growing age.

Authors:  Cesare Faldini; Matteo Nanni; Francesco Traina; Daniele Fabbri; Raffaele Borghi; Sandro Giannini
Journal:  Int Orthop       Date:  2015-10-27       Impact factor: 3.075

4.  Adolescent hallux valgus: a systematic review of outcomes following surgery.

Authors:  Ziad Harb; Michail Kokkinakis; Hiba Ismail; Gavin Spence
Journal:  J Child Orthop       Date:  2015-04-22       Impact factor: 1.548

5.  Management of Juvenile Hallux Valgus Deformity: the role of combined Hemiepiphysiodesis.

Authors:  Ming-Hung Chiang; Ting-Ming Wang; Ken N Kuo; Shier-Chieg Huang; Kuan-Wen Wu
Journal:  BMC Musculoskelet Disord       Date:  2019-10-25       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.